Article
Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jan 2018
Almodovar Karinna, Iams Wade T, Meador Catherine B, Zhao Zhiguo, York Sally, Horn Leora, Yan Yingjun, Hernandez Jennifer, Chen Heidi, Shyr Yu, Lim Lee P, Raymond Christopher K, Lovly Christine M
Abstract excerpt
INTRODUCTION: Patients with SCLC have a poor prognosis and limited treatment options. Because access to longitudinal tumor samples is very limited in patients with this disease, we chose to focus our studies on the characterization of plasma cell-free DNA (cfDNA) for rapid, noninvasive monitoring of disease burden. METHODS: We developed a liquid biopsy assay that quantifies somatic variants in cfDNA. The assay...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
